Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Basic Science and Pathogenesis
Ronald Marcus, Scott Vuocolo, Ian Ramsey, et al.
Psychiatry (Edgmont (Pa. : Township))
|
September 3, 2009
Sheehan Suicidality Tracking Scale (Sheehan-STS): Preliminary Results from a Multicenter Clinical Trial in Generalized Anxiety Disorder
Vladimir Coric, Elyse G Stock, Joseph Pultz, et al.
The Journal of Clinical Psychiatry
|
August 28, 2024
Rationale for Adjunctive Treatment Targeting Multiple Mechanisms in Schizophrenia
Bruce J Kinon, Stefan Leucht, Carol Tamminga, et al.
Bipolar Disorders
|
March 30, 2011
Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study
Ronald Marcus, Arif Khan, Linda Rollin, et al.
Cephalalgia : an International Journal of Headache
|
August 23, 2013
BMS-927711 for the acute treatment of migraine: a double-blind, randomized, placebo controlled, dose-ranging trial
Ronald Marcus, Peter J Goadsby, David Dodick, et al.
Journal of Affective Disorders
|
January 3, 2012
A 40-week double-blind aripiprazole versus lithium follow-up of a 12-week acute phase study (total 52 weeks) in bipolar I disorder
Rif S El-Mallakh, Ronald Marcus, Christine Baudelet, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
August 24, 2010
A comparison of two fixed doses of aripiprazole with placebo in acutely relapsed, hospitalized patients with bipolar disorder I (manic or mixed) in subpopulations (CN138-007)
Rif S El Mallakh, Eduard Vieta, Linda Rollin, et al.
Journal of Child and Adolescent Psychopharmacology
|
October 27, 2010
Line-item analysis of the Aberrant Behavior Checklist: results from two studies of aripiprazole in the treatment of irritability associated with autistic disorder
Michael G Aman, William Kasper, George Manos, et al.
The American Journal of Psychiatry
|
August 29, 2003
A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania
Paul E Keck, Ronald Marcus, Stavros Tourkodimitris, et al.
Journal of Child and Adolescent Psychopharmacology
|
October 22, 2013
Aripiprazole treatment of irritability associated with autistic disorder and the relationship between prior antipsychotic exposure, adverse events, and weight change
Raymond Mankoski, Gwen Stockton, George Manos, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Basic Science and Pathogenesis
Ronald Marcus, Scott Vuocolo, Ian Ramsey, et al.
Psychiatry (Edgmont (Pa. : Township))
|
September 3, 2009
Sheehan Suicidality Tracking Scale (Sheehan-STS): Preliminary Results from a Multicenter Clinical Trial in Generalized Anxiety Disorder
Vladimir Coric, Elyse G Stock, Joseph Pultz, et al.
The Journal of Clinical Psychiatry
|
August 28, 2024
Rationale for Adjunctive Treatment Targeting Multiple Mechanisms in Schizophrenia
Bruce J Kinon, Stefan Leucht, Carol Tamminga, et al.
Bipolar Disorders
|
March 30, 2011
Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study
Ronald Marcus, Arif Khan, Linda Rollin, et al.
Cephalalgia : an International Journal of Headache
|
August 23, 2013
BMS-927711 for the acute treatment of migraine: a double-blind, randomized, placebo controlled, dose-ranging trial
Ronald Marcus, Peter J Goadsby, David Dodick, et al.
Journal of Affective Disorders
|
January 3, 2012
A 40-week double-blind aripiprazole versus lithium follow-up of a 12-week acute phase study (total 52 weeks) in bipolar I disorder
Rif S El-Mallakh, Ronald Marcus, Christine Baudelet, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
August 24, 2010
A comparison of two fixed doses of aripiprazole with placebo in acutely relapsed, hospitalized patients with bipolar disorder I (manic or mixed) in subpopulations (CN138-007)
Rif S El Mallakh, Eduard Vieta, Linda Rollin, et al.
Journal of Child and Adolescent Psychopharmacology
|
October 27, 2010
Line-item analysis of the Aberrant Behavior Checklist: results from two studies of aripiprazole in the treatment of irritability associated with autistic disorder
Michael G Aman, William Kasper, George Manos, et al.
The American Journal of Psychiatry
|
August 29, 2003
A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania
Paul E Keck, Ronald Marcus, Stavros Tourkodimitris, et al.
Journal of Child and Adolescent Psychopharmacology
|
October 22, 2013
Aripiprazole treatment of irritability associated with autistic disorder and the relationship between prior antipsychotic exposure, adverse events, and weight change
Raymond Mankoski, Gwen Stockton, George Manos, et al.
Page
of 3